- Hydropothecary becomes preferred supplier to Quebec market for a five-year term.
- Total volume estimated at more than 200,000kg over five-year term
- Option to extend term for an additional year.
- Largest supply agreement between an authorized producer and a provincial authority responsible for the supply of cannabis for
the adult-use recreational market.
GATINEAU, Québec, April 11, 2018 (GLOBE NEWSWIRE) -- The Hydropothecary Corporation (“Hydropothecary” or the “Company”)
(TSXV:THCX) is pleased to announce that it has entered into a commercial agreement with the Société des alcools du Québec (SAQ) to
be the preferred supplier of cannabis products for the Quebec market for the first five years post-legalization, with an option to
extend the term for an additional year.
Under the agreement, Hydropothecary will supply 20,000 kg of products in the first year of the agreement and is expected to
supply 35,000 kg in the second year and 45,000 kg in the third. The volumes for the final two years of the agreement will be
established at a later date based on the sales generated in the first three years. The supply arrangement covers the full
range of the Company’s products and brands, from flowers to cannabis oil.
In the event the volume requirements in years four and five of the agreement amount to 49,500 kg and 54,450 kg respectively
based on an anticipated 10% growth rate in both the cannabis market and the Company’s supply requirements under the agreement, and
assuming the mix of products supplied moves towards less flower and more value-added products as anticipated, the Company estimates
the total volume to be supplied over the five-year term of the agreement could exceed 203,950kg.
The SAQ has the right to terminate the agreement in certain circumstances.
“Becoming the preferred supplier to the Quebec market out of the gate post legalization is a source of great pride and a vote of
confidence in our ability to scale operations to meet our supply commitment,” said Sébastien St-Louis, co-founder and CEO of
Hydropothecary. “This agreement marks an important step in the execution of our growth strategy, which is focused initially on the
Quebec market by expanding our Gatineau facilities and hiring new employees, and then establishing our presence in other Canadian
markets.”
“By doing business with Hydropothecary, the SAQ is engaging with a company that complies with the law and adheres to best
practices in both corporate governance and the development and manufacturing of high quality and safe products,” added Mr.
St-Louis.
Recognizing its responsibility toward Quebec and its citizens, Hydropothecary is committed to:
- working with the Government of Quebec, the future Société québécoise du cannabis (SQDC), a subsidiary of the SAQ and other
partners to implement awareness campaigns promoting responsible cannabis use; and,
- supporting research and educational programs related to the cultivation and processing of cannabis, as well as the
development of medical and recreational cannabis products in Quebec.
Hydropothecary is currently the only cannabis producer in Quebec to hold a license from Health Canada for the sale of
cannabis.
The agreement is conditional on the adoption by the federal and provincial governments of the necessary
regulatory framework.
Conference call
Hydropothecary will host a conference call for financial analysts and shareholders to discuss the SAQ supply agreement today at
8:30 am EST. The dial-in number is 1-(866) 521-4909, access code is 1776268. A replay of this call will be available afterward on
our website www.thcx.com.
About The Hydropothecary Corporation
The Hydropothecary Corporation is an authorized licensed producer and distributor of medical cannabis licensed by Health Canada
under the Access to Cannabis for Medical Purposes Regulations. Hydropothecary creates award-winning innovative, easy to use and
easy to understand products. Hydropothecary is rapidly increasing its production capacity in the lead-up to recreational adult-use
cannabis. Expansion plans will result in a total of 1.3 million sq. ft. of production space, producing 108,000 kg of dried cannabis
per year, making Hydropothecary one of the largest producers in the country. Headquartered in Quebec, Hydropothecary is one of the
lowest-cost producers in the country.
Forward-Looking Information
This press release contains forward-looking information that is based on certain assumptions and involves known and unknown
risks and uncertainties and other factors that could cause actual events to differ materially from current assumptions and
expectations. Examples of forward-looking information include, but are not limited to, the Company’s estimates of product volumes
to be supplied by it under the supply agreement with the SAQ, its assumptions regarding product mix, its assumption that the
agreement will remain in force for its full term and conditional by governments adoption of the necessary regulatory frameworks.
These statements should not be read as assurances of future performance or results. Such statements involve known and unknown
risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from
those implied by such statements, including the actual product volumes that will be supplied by the Company under the agreement,
the Company’s ability to produce the estimated product volumes, and the actual mix of products that will be supplied and their
pricing. A more complete discussion of the risks and uncertainties facing the Company appears in the Company’s Annual Information
Form and continuous disclosure filings, which are available on SEDAR’s website at www.sedar.com. Readers are cautioned not to place
undue reliance on these forward-looking statements, which speak only as of the date of this press release. The Company disclaims
any intention or obligation, except to the extent required by law, to update or revise any forward-looking statements as a result
of new information or future events, or for any other reason.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX
Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Investor Relations:
Jennifer Smith
Manager of Financial Reporting and Investor Relations
1-866-438-THCX (8429)
invest@THCX.com
www.THCX.com
Media Relations:
Shawn Lyons
Media Relations
Shawn.lyons@thehydropothecary.com
Director
Adam Miron
819-639-5498
